Learn About Paroxysmal Ventricular Fibrillation

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Paroxysmal Ventricular Fibrillation Local Doctors?
TK
Tsukasa Kamakura
Elite
Highly rated in
20
conditions

Division Of Arrhythmia And Electrophysiology

National Cerebral And Cardiovascular Center 
Osaka, JP 

Tsukasa Kamakura is in Osaka, Japan. Kamakura is rated as an Elite expert by MediFind in the treatment of Paroxysmal Ventricular Fibrillation. He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are Paroxysmal Ventricular Fibrillation, Ventricular Fibrillation, Brugada Syndrome, and Arrhythmias.

View Profile
TS
Tobias Schupp
Elite
Highly rated in
7
conditions

University Medical Center Mannheim

Mannheim, BW, DE 68167

Tobias Schupp is in Mannheim, Germany. Schupp is rated as an Elite expert by MediFind in the treatment of Paroxysmal Ventricular Fibrillation. He is also highly rated in 7 other conditions, according to our data. His top areas of expertise are Paroxysmal Ventricular Fibrillation, Ventricular Fibrillation, Paroxysmal Supraventricular Tachycardia, and Paroxysmal Supraventricular Tachycardia.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
KA
Kazutaka Aonuma
Elite
Highly rated in
30
conditions

University Of Tsukuba

Faculty Of Medicine 
Tsukuba, JP 

Kazutaka Aonuma is in Tsukuba, Japan. Aonuma is rated as an Elite expert by MediFind in the treatment of Paroxysmal Ventricular Fibrillation. They are also highly rated in 30 other conditions, according to our data. Their top areas of expertise are Paroxysmal Ventricular Fibrillation, Ventricular Fibrillation, Atrial Fibrillation, and Arrhythmias.

View Profile
View All Doctors
What are the Latest Advances for Paroxysmal Ventricular Fibrillation?
Long-term outcome after thoracoscopic cardiac sympathectomy for refractory ventricular tachyarrhythmia storm.
Condition: Refractory Ventricular Tachyarrhythmia Storm
Journal: BMJ case reports
Treatment Used: Thoracoscopic Cardiac Sympathectomy
Number of Patients: 1
Published: March 30, 2022
View publication
Summary: Long-term outcome after thoracoscopic cardiac sympathectomy for refractory ventricular tachyarrhythmia storm.
Treatment of status epilepticus and prolonged QT after massive intentional bupropion overdose with lidocaine.
Condition: Status Epilepticus and Prolonged QT after Massive Intentional Bupropion Overdose
Journal: The American journal of emergency medicine
Treatment Used: Lidocaine
Number of Patients: 1
Published: March 11, 2022
View publication
Summary: Treatment of status epilepticus and prolonged QT after massive intentional bupropion overdose with lidocaine.
Tired of the same old research?
Check Latest Advances
Bilateral cardiac sympathetic denervation for refractory arrhythmia in an individual with catecholaminergic polymorphic ventricular tachycardia associated with T-cell-mediated ganglionitis.
Condition: Refractory Arrhythmia
Journal: BMJ case reports
Treatment Used: Bilateral Cardiac Sympathetic Denervation
Number of Patients: 1
Published: February 15, 2022
View publication
Summary: Bilateral cardiac sympathetic denervation for refractory arrhythmia in an individual with catecholaminergic polymorphic ventricular tachycardia associated with T-cell-mediated ganglionitis.
View All Latest Advances
What are the latest Paroxysmal Ventricular Fibrillation Clinical Trials?
Utility and Procedural Feasibility of REBOA Operationalized for Non-Trauma Application (UP-FRONT)
Status: Not yet recruiting
Start Date: June 1, 2022
Intervention Type: Device
Phase: Not Applicable
View Trial
Summary: Single center randomized-controlled trial in out-of-hospital cardiac arrest (OHCA) patients. This study will investigate the feasibility and utility of the Endovascular Balloon Occlusion of the aorta procedure using the Neurescue™ device in patients who have experienced an OHCA and have not regained return of spontaneous circulation (ROSC).
Match to trials
Find the right clinical trials for you in under a minute
Get started
CanROC Epinephrine Dose: Optimal Versus Standard Evaluation Trial (CanROC EpiDOSE Trial)
Status: Not yet recruiting
Start Date: October 2021
Intervention Type: Drug
Phase: Phase 4
View Trial
Summary: The objective of this randomized controlled trial is to evaluate the effectiveness of a low cumulative dose of epinephrine compared to a standard cumulative dose of epinephrine during resuscitation from ventricular fibrillation (VF) or ventricular tachycardia (VT) in adult out-of-hospital cardiac arrest (OHCA) patients.
View All Clinical Trials